Viropro Stock Market Value

Viropro's market value is the price at which a share of Viropro trades on a public exchange. It measures the collective expectations of Viropro investors about its performance.
With this module, you can estimate the performance of a buy and hold strategy of Viropro and determine expected loss or profit from investing in Viropro over a given investment horizon. Check out Viropro Correlation, Viropro Volatility and Viropro Alpha and Beta module to complement your research on Viropro.
To learn how to invest in Viropro Stock, please use our How to Invest in Viropro guide.
Symbol

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viropro. If investors know Viropro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viropro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Viropro is measured differently than its book value, which is the value of Viropro that is recorded on the company's balance sheet. Investors also form their own opinion of Viropro's value that differs from its market value or its book value, called intrinsic value, which is Viropro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viropro's market value can be influenced by many factors that don't directly affect Viropro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viropro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viropro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viropro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Viropro 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Viropro's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Viropro.
0.00
01/06/2024
No Change 0.00  0.0 
In 1 year 11 months and 22 days
12/26/2025
0.00
If you would invest  0.00  in Viropro on January 6, 2024 and sell it all today you would earn a total of 0.00 from holding Viropro or generate 0.0% return on investment in Viropro over 720 days. Viropro Inc., through its subsidiaries, engages in the contract research, development, and manufacture of biotherapeutic... More

Viropro Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Viropro's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Viropro upside and downside potential and time the market with a certain degree of confidence.

Viropro Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Viropro's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Viropro's standard deviation. In reality, there are many statistical measures that can use Viropro historical prices to predict the future Viropro's volatility.
Hype
Prediction
LowEstimatedHigh
0.000.000020.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000130.00
Details
Naive
Forecast
LowNextHigh
0.0000010.0000010.000001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.000000330.000000330.00000033
Details

Viropro Backtested Returns

Viropro is very steady given 3 months investment horizon. Viropro owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.13, which indicates the firm had a 0.13 % return per unit of risk over the last 3 months. We were able to interpolate data for twelve different technical indicators, which can help you to evaluate if expected returns of 15.63% are justified by taking the suggested risk. Use Viropro Risk Adjusted Performance of 0.0979, coefficient of variation of 800.0, and Variance of 15625.0 to evaluate company specific risk that cannot be diversified away. Viropro holds a performance score of 9 on a scale of zero to a hundred. The entity has a beta of -0.47, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Viropro are expected to decrease at a much lower rate. During the bear market, Viropro is likely to outperform the market. Use Viropro market risk adjusted performance and treynor ratio , to analyze future returns on Viropro.

Auto-correlation

    
  0.00  

No correlation between past and present

Viropro has no correlation between past and present. Overlapping area represents the amount of predictability between Viropro time series from 6th of January 2024 to 31st of December 2024 and 31st of December 2024 to 26th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Viropro price movement. The serial correlation of 0.0 indicates that just 0.0% of current Viropro price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test-0.16
Residual Average0.0
Price Variance0.0

Viropro lagged returns against current returns

Autocorrelation, which is Viropro stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Viropro's stock expected returns. We can calculate the autocorrelation of Viropro returns to help us make a trade decision. For example, suppose you find that Viropro has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Viropro regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Viropro stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Viropro stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Viropro stock over time.
   Current vs Lagged Prices   
       Timeline  

Viropro Lagged Returns

When evaluating Viropro's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Viropro stock have on its future price. Viropro autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Viropro autocorrelation shows the relationship between Viropro stock current value and its past values and can show if there is a momentum factor associated with investing in Viropro.
   Regressed Prices   
       Timeline  

Pair Trading with Viropro

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Viropro position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viropro will appreciate offsetting losses from the drop in the long position's value.

Moving against Viropro Stock

  0.39DWTX Dogwood Therapeutics, Upward RallyPairCorr
The ability to find closely correlated positions to Viropro could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Viropro when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Viropro - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Viropro to buy it.
The correlation of Viropro is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Viropro moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Viropro moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Viropro can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Viropro offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Viropro's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Viropro Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Viropro Stock:
Check out Viropro Correlation, Viropro Volatility and Viropro Alpha and Beta module to complement your research on Viropro.
To learn how to invest in Viropro Stock, please use our How to Invest in Viropro guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Viropro technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Viropro technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Viropro trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...